Stephen Krieger, MD, joined The Corinne Goldsmith Dickinson Center for MS as a fellow in multiple sclerosis after completing his Neurology residency training at Mount Sinai.

He was the recipient of a 2006 American Academy of Neurology Scholarship and received a Sylvia Lawry Fellowship in clinical research from the National Multiple Sclerosis Society.  He graduated summa cum laude from Columbia College, and received his MD degree from Yale University.

Dr. Krieger has a clinical practice at the CGDC for MS, and is participating in several MS clinical trials, including oral therapies and monoclonal antibodies used as disease-modifying agents for MS.  In addition to his clinical work, he has an academic appointment as Associate Professor of Neurology at the Icahn School of Medicine at Mount Sinai, where he is Director of the Neurology Residency Training program, and a member of the Neurology Education Committee. He has also served as director of the Brain and Behavior seminar series for the medical school.

Dr. Krieger is on several advisory boards and steering committees in the field of Multiple Sclerosis, and is an active member of the American Academy of Neurology (AAN) who awarded him an A.B. Baker teaching recognition award in 2010. He has presented work at AAN, CMSC, ACTRIMS, and ECTRIMS and has written review articles on and lectures nationally about MS with an emphasis on emerging therapies. In 2015 Dr. Krieger proposed the Topographical Model of MS, a new conceptualization of MS disease course that was accepted for presentation at several national/international meetings and was the subject of an article in Scientific American.